SEC Form 4 · accession 0001140361-18-014498
ROCKWELL MEDICAL, INC. · RMTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald D Boyd
Director
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001041024
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.75 | Mar 19, 2018 | A | 36,139 | A | Mar 19, 2019 | Mar 19, 2028 | Common Stock | 36,139 | 36,139 | D |
Explanation of responses
- F1The grant of these options is contingent upon shareholder approval of the 2018 Rockwell Medical, Inc. Long Term Incentive Plan (the "2018 Plan") at the Company's 2018 Annual Meeting of Shareholders. If the Company's shareholders do not approve the 2018 Plan, these contingent options are deemed null and void and may not be exercised by the reporting person.